Sol-Gel Technologies (FRA:4SG) FFO


FRA:4SG Sol-Gel Technologies Ltd FRA:4SG
54 GF Score
Price €63.00
GF Value €55.51
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is Sol-Gel Technologies FFO?

FFO (Funds from operations) only applies to REITs.

FRA:4SG
54GF Score
Sol-Gel Technologies Ltd FRA:4SG
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Sol-Gel Technologies (FRA:4SG) Overvalued in 2026?

Based on GuruFocus' analysis, Sol-Gel Technologies stock appears to be overvalued. The current stock price of €63.00 is trading 13.5% above its estimated GF Value™ of €55.51. GuruFocus considers Sol-Gel Technologies to be Modestly Overvalued.

Key valuation signals for FRA:4SG:

  • FFO:
  • GF Value™: €55.51 vs. price of €63.00 (13.5% above fair value)
  • GF Score™: 54/100 with 2 warning signs

No single metric tells the full story. See the FRA:4SG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sol-Gel Technologies Business Description

Other Exchanges SLGL:USA
Address 7 Golda Meir Street, Weizmann Science Park, Ness Ziona, ISR, 7403650
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted. It generates the majority of its revenue from the United States.
54GF Score

Get the complete analysis for FRA:4SG

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€63.00
Price
€55.51
GF Value